GSK plc
Last · —$1844.50+28.50 (+1.57%)live · yahoo · 0s ago
Market cap——
P/E · TTM15.0fwd — · eps —
Beta—vs S&P 500
Div yield—annual · TTM
52w range
——
Volume—session
| Revenue | £32.7B |
|---|---|
| Operating income | £7.9B |
| Net income | £5.7B |
| Free cash flow | £6.4B |
| Operating margin | 24.3% |
| Net margin | 17.5% |
| Return on equity | 34.9% |
| Period | 2025 |
Loading chart…
OpenFilings analyst
Our analyst
From latest ANNUAL · 2026-04-26
- Current Ratio Low
Red flags
- Current Ratio Low — Current ratio 0.82
Upcoming earnings
4:30 PM UTC+1
Period
Sep 2026
Est. EPS
$0.50
Est. revenue
8.8B
Earnings transcripts
Press & signals
- Satelight
Fantasy M&A: the recipe for a European champion
- Satelight
Biotech deals surge to record as fear of missing out grips Big Pharma
- Satelight
GSK in talks to buy cancer biotech Nuvalent for more than $9bn
The rest of this company's wire — with summaries and source links — is part of Pro.
See plans